|Age:||Over 6 years old|
|Keywords:||dog, canine, CHF, congestive heart failure, myxomatous mitral valve disease, MMVD, clevidipine|
|Type:||Drug - Treatment|
If the exams, tests, and procedures show that your pet can take part in the study, and you choose to enroll them, then the following will happen as part of the study:
If you wish to have your pet participate in this study, you will be responsible for covering costs associated with the standard hospitalization costs and initial presentation to the hospital (emergency examination, initial intravenous catheter placement) and diagnostics recommended by your veterinarian that fall outside of the costs covered by the study.
PLEASE BRING YOUR DOG WITH CONGESTIVE HEART FAILURE DIRECTLY TO THE UC DAVIS VMTH EMERGENCY ROOM!
We are looking for dogs over 5.5 pounds and older than 6 years old that are diagnosed with, or have clinical signs suggestive of, congestive heart failure (fluid in the lungs) as a result of myxomatous mitral valve disease (age-related change during which the mitral heart valve thickens, which makes blood leaking backwards into the top chamber of the heart).
We cannot include dogs taking medications that alter blood pressure (other than pimobendan, ACE-inhibitors or diuretics) within 4 days of enrollment, that have significant systemic (e.g., kidney disease) or cardiac disease other than MMVD, or that have significant arrhythmias.
To find out if your dog can take part in the study, we will need:
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.